Use

MI Tumor Seek Hybrid is a laboratory developed test (LDT) that performs high-throughput Next-Generation Sequencing (NGS) to capture both DNA and RNA, combining Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) of over 23,000 genes. It provides a comprehensive molecular blueprint to guide clinical decisions, helping to confirm diagnosis and optimize therapy selection using predictive AI signatures like Caris GPSai and FOLFIRSTai.